Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Sep 30, 2012

Filed with the SEC on Nov 13, 2012 and accepted by EDGAR at Nov 13, 2012, 18:38 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2012-07-01 to 2012-09-30$23us-gaap:Revenues
Revenue9 months2012-01-01 to 2012-09-30$561us-gaap:Revenues
Gross profit3 months2012-07-01 to 2012-09-30$23us-gaap:GrossProfit
Gross profit9 months2012-01-01 to 2012-09-30$561us-gaap:GrossProfit
Interest expense3 months2012-07-01 to 2012-09-30−$49us-gaap:InterestExpense
Interest expense9 months2012-01-01 to 2012-09-30−$169us-gaap:InterestExpense
Net income3 months2012-07-01 to 2012-09-30−$4.8kus-gaap:NetIncomeLoss
Net income9 months2012-01-01 to 2012-09-30−$12.5kus-gaap:NetIncomeLoss
Operating cash flow9 months2012-01-01 to 2012-09-30−$12.4kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2012-09-30$1.5kus-gaap:Cash
Current assetsAt period end2012-09-30$1.5kus-gaap:AssetsCurrent
Total assetsAt period end2012-09-30$1.5kus-gaap:Assets
Current liabilitiesAt period end2012-09-30$4.8kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2012-09-30$17.3kus-gaap:Liabilities
Shareholders' equityAt period end2012-09-30−$15.8kus-gaap:StockholdersEquity
Shares outstandingAt period end2012-09-305,073,000 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001014897-12-000361. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.